Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
32
Top-10 weight
69.80%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
15
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1066.5
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 3,077 | $2.83M | 15.59% |
| 2 | US BANK MMDA - USBGFS 7 | USBGFS7 | 1,820,804 | $1.82M | 10.03% |
| 3 | ABBVIE INC | — | 7,034 | $1.53M | 8.43% |
| 4 | Novartis AG | — | 8,791 | $1.34M | 7.40% |
| 5 | JOHNSON&JOHNSON | — | 4,401 | $1.08M | 5.93% |
| 6 | ASTRAZENECA PLC | — | 5,256 | $1.04M | 5.71% |
| 7 | BRISTOL-MYERS SQUIBB CO | — | 15,348 | $930.86K | 5.13% |
| 8 | IONIS PHARMACEUTICALS INC | — | 11,428 | $858.13K | 4.73% |
| 9 | AMGEN INC | — | 2,161 | $760.35K | 4.19% |
| 10 | ALNYLAM PHARMACEUTICALS INC | — | 2,272 | $751.74K | 4.14% |
| 11 | ALKERMES PLC | — | 21,099 | $746.06K | 4.11% |
| 12 | MERCK & CO | — | 6,154 | $740.26K | 4.08% |
| 13 | PFIZER INC | — | 23,736 | $666.51K | 3.67% |
| 14 | GSK plc SPONSORED ADR | GSK US | 10,319 | $569.51K | 3.14% |
| 15 | BIOGEN INC | — | 2,857 | $523.77K | 2.89% |
| 16 | REGENERON PHARMACEUTICALS INC | — | 660 | $509.94K | 2.81% |
| 17 | CRISPR THERAPEUTICS AG | — | 9,671 | $460.05K | 2.53% |
| 18 | BEAM THERAPEUTICS INC | — | 8,791 | $209.49K | 1.15% |
| 19 | INTELLIA THERAPEUTICS INC | — | 13,188 | $169.07K | 0.93% |
| 20 | VANDA PHARMACEUTICALS INC | — | 23,736 | $164.02K | 0.90% |
| 21 | Sandoz Group AG SPONSORED ADS | SDZNY | 1,760 | $137.63K | 0.76% |
| 22 | GALECTIN THERAPEUTICS INC | — | 49,226 | $137.34K | 0.76% |
| 23 | HALEON PLC SPONS ADR | HLN US | 12,900 | $129.13K | 0.71% |
| 24 | REPLIMUNE GROUP INC | — | 13,188 | $100.89K | 0.56% |
| 25 | EDITAS MEDICINE INC | — | 29,010 | $71.65K | 0.39% |
| 26 | GE HEALTHCARE TECHNOLOGIES INC WI | — | 880 | $62.64K | 0.35% |
| 27 | Bicycle Therapeutics PLC SPONSORED ADS | BCYC US | 13,188 | $61.19K | 0.34% |
| 28 | VIATRIS INC | — | 3,272 | $44.20K | 0.24% |
| 29 | ALLOGENE THERAPEUTICS INC | — | 17,582 | $42.90K | 0.24% |
| 30 | LANTERN PHARMA INC | — | 26,373 | $36.13K | 0.20% |
| 31 | PACIFIC BIOSCIENES OF CALI INC | — | 10,551 | $13.93K | 0.08% |
| 32 | Decoy Therapeutics Inc | — | 21 | $136 | 0.00% |
| 33 | Pathos AI Inc | 2368714D | 23,992 | $0 | 0.00% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.